The CEO of Epitek is Steven Baranowitz, MD MS MBA. Having served as Medical Director at several major pharmaceutical companies, Dr. Baranowitz brings a wealth of pharmaceutical industry experience to Epitek. He is a recognized expert in pharmaceutical Drug Safety and Clinical Trials and has consulted for many biotechnology and pharmaceutical companies in these areas.

Dr. Baranowitz is an inventor with over ten US and International Patents on new potential treatments for a variety of diseases, in fields including oncology, gastroenterology, ophthalmology, and regenerative medicine.

A graduate of the New York University School of Medicine, Dr. Baranowitz completed specialty training in dermatology at Mount Sinai Hospital in New York. He was also a Research Fellow sponsored by the National Institutes of Health. He obtained research expertise in Developmental Biology while earning his Master of Science degree from the University of Michigan in Ann Arbor and his Bachelor of Science degree at Brooklyn College. Dr. Baranowitz was honored by the University of Oxford in England when its Center for Mathematical Biology sponsored him as a Visiting Scientist. As a guest of the University, he lectured and collaborated in original research. During his stay, he also gave an invited guest seminar at the National Institute for Medical Research in London. Dr. Baranowitz has presented papers at international symposia and his research has been published several scientific journals including the Journal of Theoretical Biology and the New England Journal of Medicine.